US Patent 7683171 1
Patent 7683171 was granted and assigned to Bristol-Myers Squibb on March, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 27 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+116 characters)
Article
Patent abstract
The present invention provides for thiazolopyridine-based tricyclic compounds having the formula (I),
Edits on 7 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07683171 1 US Patent 7683171 1
Infobox
Patent Number
0768317100
Patent Number
768317100
Edits on 21 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076831710
Date of Patent
March 23, 2010
0Patent Application Number
113469860
Date Filed
February 3, 2006
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076831710
Date of Patent
March 23, 2010
0Patent Application Number
113469860
Date Filed
February 3, 2006
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07683171 1
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07683171
Date of patent
March 23, 2010
Patent application number
11346986
Date Filed
February 3, 2006
Patent primary examiner
Find more entities like US Patent 7683171 1
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
